tykhr
sign in
free sign up
Takeda Pharmaceutical Co Ltd ADR
Drug Manufacturers - Specialty & Generic
Healthcare
TAK
1.57 B shares
NYSE US
traded
23 Sep 2025
listed
no
open
15.04
52 week high
15.52
high
15.10
52 week low
0.00
low
15.03
growth
4.15 %
previous Close
15.01
P/E ratio
market cap
48.07 B
div yield
0
usd
Mar 2025
qoq
revenue
1.05 T
-7.93 %
net incoming
-103.16 B
-533.62 %
eps
0.00 %
-576.15 %
eps surprise
-37.11 %
net profit margin
-9.79 %
-11.00 %
operating incoming
41.54 B
285.05 %
net change in cash
-99.31 B
74.39 %
cash on hand
385 B
-22.06 %
cost of revenue
382 B
-8.35 %
top